Api News: Read Latest News & Live Updates on Api, Photos, Videos at CNBCTV18.com

homeApi News

Api NEWS

All

business | Feb 6, 2024 1:07 PM IST
Alembic Pharma targets 5-6 new product launches in US every quarter
business | Apr 28, 2023 12:11 PM IST
PI Industries shares surge after twin acquisitions in Pharma API, CDMO space
market | Jul 27, 2021 4:38 PM IST
Aurobindo Unit 1 likely under US FDA scanner
earnings | May 28, 2021 1:26 PM IST
Glenmark Pharma Q4FY21 preview: Street expects 3% revenue growth
healthcare | May 11, 2021 4:21 PM IST
COVID drug shortage: Experts discuss supply scenario, raw material price rise
market | Apr 22, 2021 12:54 PM IST
Good time to accumulate banks, financials; wary of inflation: DSP Investment’s Sambre
business | Feb 18, 2021 4:21 PM IST
Pharma PLI scheme: Aurobindo receives approval to manufacture 3 drug intermediates
healthcare | Dec 8, 2020 3:55 PM IST
Will take some time to shift API volumes from China to India: Granules India
healthcare | Nov 26, 2020 1:56 PM IST
Pharma PLI Scheme: Industry worried about large capex & tough competition
market | Oct 7, 2020 3:57 PM IST
Macquarie raises TP on Solara Active Pharma by over 40%, says re-rating to continue
business | Sept 8, 2020 1:34 PM IST
Looking at Rs 100 cr revenues in next 5 years from new OTC segment, says Shilpa Medicare
market | Aug 25, 2020 1:30 PM IST
Q1FY21 Review: Pharma cos posted stellar results but industry not out of the woods, says JM Financial
healthcare | Jul 27, 2020 8:20 PM IST
Govt launches pharma manufacturing schemes; fruits to be visible in next two years
healthcare | Jul 27, 2020 6:37 PM IST
Govt incentivises manufacturing of APIs & medical devices; here’s what it means for the sector
photos | Feb 27, 2020 3:13 PM IST
These 5 smallcap pharmaceuticals have climbed upto over 160% this month

Api NEWS

Alembic Pharma targets 5-6 new product launches in US every quarter

PI Industries shares surge after twin acquisitions in Pharma API, CDMO space

Aurobindo Unit 1 likely under US FDA scanner

Glenmark Pharma Q4FY21 preview: Street expects 3% revenue growth

COVID drug shortage: Experts discuss supply scenario, raw material price rise

Good time to accumulate banks, financials; wary of inflation: DSP Investment’s Sambre

Pharma PLI scheme: Aurobindo receives approval to manufacture 3 drug intermediates

Will take some time to shift API volumes from China to India: Granules India

Pharma PLI Scheme: Industry worried about large capex & tough competition

Macquarie raises TP on Solara Active Pharma by over 40%, says re-rating to continue

Looking at Rs 100 cr revenues in next 5 years from new OTC segment, says Shilpa Medicare

Q1FY21 Review: Pharma cos posted stellar results but industry not out of the woods, says JM Financial

Govt launches pharma manufacturing schemes; fruits to be visible in next two years

Govt incentivises manufacturing of APIs & medical devices; here’s what it means for the sector

These 5 smallcap pharmaceuticals have climbed upto over 160% this month